Avity Investment Management Inc. Amgen Inc Transaction History

Avity Investment Management Inc.

$1.42 Billion
Q3 2025

A detailed history of Avity Investment Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Avity Investment Management Inc. holds 73,373 shares of AMGN stock, worth $25.1 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

73,373

Previous 106,139 30.87%

Holding current value

$25.1 Million

Previous $29.6 Million 30.13%

% of portfolio

1.45%

Previous 2.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	SELL	$271.18 - $309.22 $8.89 Million - $10.1 Million	-32,766 Reduced 30.87%	73,373 $20.7 Million
Q2 2025 Jul 08, 2025	BUY	$262.28 - $309.85 $952,076 - $1.12 Million	3,630 Added 3.54%	106,139 $29.6 Million
Q1 2025 Apr 11, 2025	SELL	$258.59 - $327.36 $66,457 - $84,131	-257 Reduced 0.25%	102,509 $31.9 Million
Q4 2024 Jan 14, 2025	SELL	$258.78 - $328.31 $2.04 Million - $2.58 Million	-7,865 Reduced 7.11%	102,766 $26.8 Million
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $2.04 Million - $2.23 Million	-6,609 Reduced 5.64%	110,631 $35.6 Million

Q2 2024 Jul 11, 2024	SELL	$262.75 - $319.31 $342,100 - $415,741	-1,302 Reduced 1.1%	117,240 $36.6 Million
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $612,485 - $739,347	-2,278 Reduced 1.89%	118,542 $33.7 Million
Q4 2023 Jan 11, 2024	BUY	$255.7 - $288.46 $1.33 Million - $1.5 Million	5,190 Added 4.49%	120,820 $34.8 Million
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $1.74 Million - $2.16 Million	-7,942 Reduced 6.43%	115,630 $31.1 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $225,840 - $267,051	1,054 Added 0.86%	123,572 $27.4 Million
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $1.21 Million - $1.47 Million	5,344 Added 4.56%	122,518 $29.6 Million
Q4 2022 Jan 12, 2023	BUY	$229.03 - $291.01 $701,289 - $891,072	3,062 Added 2.68%	117,174 $30.8 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $9.68 Million - $10.9 Million	43,130 Added 60.76%	114,112 $25.7 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $15.7 Million - $17.5 Million	68,257 Added 2504.84%	70,982 $17.3 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $5,481 - $6,064	-25 Reduced 0.91%	2,725 $659,000
Q2 2021 Jul 13, 2021	SELL	$233.58 - $259.14 $23,358 - $25,914	-100 Reduced 3.51%	2,750 $670,000
Q1 2021 Apr 15, 2021	SELL	$221.91 - $258.6 $66,573 - $77,580	-300 Reduced 9.52%	2,850 $709,000
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $11,732 - $13,047	-50 Reduced 1.56%	3,150 $801,000
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 1.54%	3,200 $755,000
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $45,560 - $60,425	-250 Reduced 7.14%	3,250 $659,000
Q4 2019 Jan 15, 2020	BUY	$189.21 - $243.2 $18,921 - $24,320	100 Added 2.94%	3,500 $844,000
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $65,291 - $78,232	375 Added 12.4%	3,400 $658,000
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $504,267 - $591,115	3,025 New	3,025 $557,000

Others Institutions Holding AMGN

# of Institutions

3,276

Shares Held

428M

Call Options Held

6.17M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avity Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avity Investment Management Inc. with notifications on news.

Account

Avity Investment Management Inc. Amgen Inc Transaction History